You are here: Industry Insights > Drug Discovery

News List

Singapore biotech startup raises $10M to enhance drug discovery biospectrumasia
February 13, 2018
The money will be used to further develop its drug discovery platform, hire more scientists in its home bases of San Francisco and Singapore and pursue medical studies.
Drug Discovery IT Solutions to Hit $5.3 Billion Globally by 2020 prnasia
January 11, 2018
Growth Insights -- Global Pharmaceutical Drug Discovery IT Solutions Market, Forecast to 2020, by Frost & Sullivan highlights the growing interest in big data analytics and artificial intelligence (AI)-based solutions
Concept Life Sciences expands into Alderley Park to support discovery services growth pharmaasia
September 15, 2017
Concept Life Sciences (Concept), the integrated drug discovery, development and analytical services company, has expanded into new state-of-the-art laboratory space at Alderley Park in Cheshire, U
Zai Lab’s $115M IPO, Takeda-Stanford R&D deal, Chinese firms’ bids for Arbor fiercepharma
August 21, 2017
Pfizer alum Samantha Du's cancer biotech Zai Lab has filed for a $115 million U.S. IPO.
Takeda R&D reboot continues with Stanford drug discovery deal fiercebiotech
August 17, 2017
Four to eight projects will be run by the partners at any given time.
Exscientia, GSK Enter into Drug Discovery Collaboration americanpharmaceuticalreview
July 04, 2017
Exscientia has entered into a strategic drug discovery collaboration with GlaxoSmithKline (GSK).
Exscientia enters strategic drug discovery collaboration with GSK cphi-online
July 04, 2017
Pre-clinical collaboration focused on up to 10 targets nominated by GSK.
Numerate and Takeda Enter Drug Discovery Alliance contractpharma
June 14, 2017
Will generate novel clinical candidates using AI-driven drug discovery
Sanofi and Exscientia Pen €250M Drug Discovery Deal contractpharma
May 10, 2017
Exscientia, an innovative company at the forefront of Artificial Intelligence (AI)-driven drug discovery, has entered a strategic research collaboration and license option agreement with Sanofi in the area of metabolic disease.
IBM Patents Machine Learning Models for Drug Discovery americanpharmaceuticalreview
April 10, 2017
IBM announced that its scientists have been granted a patent on machine learning models to predict therapeutic indications and side effects from various drug information sources.

Previous page 1 2 3 4 5 6 7 Next page